NCT06024785

Brief Summary

To assess the need for additional fusion surgery versus the risk of a revision surgery in patients with degenerative lumbar spinal disease and to assess efficacy and risk of the ligamentous fixation technique (vertebropexy)

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
164

participants targeted

Target at P75+ for not_applicable

Timeline
31mo left

Started Jan 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress34%
Jan 2025Dec 2028

First Submitted

Initial submission to the registry

August 14, 2023

Completed
23 days until next milestone

First Posted

Study publicly available on registry

September 6, 2023

Completed
1.4 years until next milestone

Study Start

First participant enrolled

January 16, 2025

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2028

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

February 13, 2025

Status Verified

November 1, 2024

Enrollment Period

3.6 years

First QC Date

August 14, 2023

Last Update Submit

February 11, 2025

Conditions

Keywords

degenerative lumbar spinal diseasedecompressionfusionvertebropexyligamentous fixation

Outcome Measures

Primary Outcomes (1)

  • ODI (Oswestry Disability Index)

    To assess and compare the clinical outcome of patients with spinal canal stenosis or foraminal stenosis +/- degenerative listhesis with either vertebropexy, decompression or fusion surgery

    2 years postoperative

Secondary Outcomes (11)

  • VAS (Visual Analogue Scale)

    2 years postoperative

  • SSM symptoms/function (Spinal Stenosis Measure)

    2 years postoperative

  • SSM satisfaction (Spinal Stenosis Measure)

    2 years postoperative

  • EQ-5D (European Quality of Life Five Dimension)

    2 years postoperative

  • Revision surgery

    2 years postoperative

  • +6 more secondary outcomes

Study Arms (4)

Indication for decompression, randomization for decompression

ACTIVE COMPARATOR

microsurgical (i.e., the use of a microscope or magnifying glasses during decompression) lumbar laminotomy with partial removal of the medial facet joint by preserving the midline structures (supraspinous-interspinous ligament complex); approach: bilateral or ipsilateral with cross-over to the contralateral side

Procedure: Vertebropexy

Indication for decompression, randomization for vertebropexy

EXPERIMENTAL

decompression (see above) and additional stabilization of the spine with a ligament (for instance semitendinosus donor allograft), which connect the postoprior structures (Proc. Spinosus and/or Lamina) of the vertebrae . Situation-related application of laminar bands or analogous suture material (for instance FiberTape, Arthrex, Naples or Nile Band, K2M, Virginia)

Procedure: Vertebropexy

Indication for fusion, randomization for fusion

ACTIVE COMPARATOR

decompression (see above) and posterolateral instrumented fusion (arthrodesis) with implantation of pedicle screws, titanium alloy rods across the level of listhesis, an intervertebral fusion device and local autograft as well as DBX (demineralized bone matrix) to improve bony fusion

Procedure: Vertebropexy

Indication for fusion, randomization for vertebropexy

EXPERIMENTAL

decompression (see above) and additional stabilization of the spine with a ligament (for instance semitendinosus donor allograft), which connect the postoprior structures (Proc. Spinosus and/or Lamina) of the vertebrae . Situation-related application of laminar bands or analogous suture material (for instance FiberTape, Arthrex, Naples or Nile Band, K2M, Virginia)

Procedure: Vertebropexy

Interventions

VertebropexyPROCEDURE

microsurgical (i.e., the use of a microscope or magnifying glasses during decompression) lumbar laminotomy with partial removal of the medial facet joint by preserving the midline structures (supraspinous-interspinous ligament complex); approach: bilateral or ipsilateral with cross-over to the contralateral side. Additional stabilization of the spine with a ligament (for instance semitendinosus donor allograft), which connect the postoprior structures (Proc. Spinosus and/or Lamina) of the vertebrae . Situation-related application of laminar bands or analogous suture material (for instance FiberTape, Arthrex, Naples or Nile Band, K2M, Virginia)

Also known as: ligamentous fixation of the spine
Indication for decompression, randomization for decompressionIndication for decompression, randomization for vertebropexyIndication for fusion, randomization for fusionIndication for fusion, randomization for vertebropexy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Single-level or two-level lumbar surgery needed
  • Indication for decompression surgery in patients with spinal canal stenosis and additional stable degenerative listhesis (without facet joint effusion ≥ 2mm)
  • Indication for fusion surgery in patients with spinal canal stenosis and additional unstable degenerative listhesis (facet joint effusion ≥ 2mm), in patients with foraminal stenosis and additional degenerative listhesis, and in patients with segment degeneration of the disc
  • Understanding in German language

You may not qualify if:

  • Indication for decompression and/or fusion surgery in patients with solely disc herniation, fractures, lytic listhesis, tumor
  • Patients undergoing revision surgery for infection
  • Patients undergoing revision surgery on the same level if bony structures have been removed (e.g. prior laminectomy or midline decompression)
  • Patients undergoing revision surgery in case of prior fusion surgery
  • Inability to understand the study for linguistic or cognitive reasons
  • Participation in other clinical trials

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Balgrist University Hospital

Zurich, 8008, Switzerland

RECRUITING

Related Publications (4)

  • Widmer J, Cornaz F, Scheibler G, Spirig JM, Snedeker JG, Farshad M. Biomechanical contribution of spinal structures to stability of the lumbar spine-novel biomechanical insights. Spine J. 2020 Oct;20(10):1705-1716. doi: 10.1016/j.spinee.2020.05.541. Epub 2020 May 28.

    PMID: 32474224BACKGROUND
  • Farshad M, Tsagkaris C, Widmer J, Fasser MR, Cornaz F, Calek AK. Vertebropexy as a semi-rigid ligamentous alternative to lumbar spinal fusion. Eur Spine J. 2023 May;32(5):1695-1703. doi: 10.1007/s00586-023-07647-y. Epub 2023 Mar 17.

    PMID: 36930387BACKGROUND
  • Calek AK, Widmer J, Fasser MR, Farshad M. Lumbar vertebropexy after unilateral total facetectomy. Spine J. 2023 Nov;23(11):1730-1737. doi: 10.1016/j.spinee.2023.07.005. Epub 2023 Jul 13.

    PMID: 37451550BACKGROUND
  • Calek AK, Altorfer F, Fasser MR, Widmer J, Farshad M. Interspinous and spinolaminar synthetic vertebropexy of the lumbar spine. Eur Spine J. 2023 Sep;32(9):3183-3191. doi: 10.1007/s00586-023-07798-y. Epub 2023 Jun 7.

    PMID: 37284900BACKGROUND

MeSH Terms

Conditions

Spinal Stenosis

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal Diseases

Central Study Contacts

Mazda Farshad, MD

CONTACT

Sabrina Catanzaro, RN

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
There is no blinding.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: * Stratification: Indication for decompression (study arm 1) or fusion (study arm 2) * Randomization within study arm 1 and study arm 2 between study intervention and control intervention
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 14, 2023

First Posted

September 6, 2023

Study Start

January 16, 2025

Primary Completion (Estimated)

September 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

February 13, 2025

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

The investigators affirm and uphold the principle of the participant's right to privacy and that they shall comply with applicable privacy laws. Especially, anonymity of the participants shall be guaranteed when presenting the data at scientific meetings or publishing them in scientific journals. Individual subject medical information obtained as a result of this study is considered confidential and disclosure to third parties is prohibited. Subject confidentiality will be further ensured by utilising subject identification code numbers to correspond to treatment data in the computer files. For data verification purposes, authorised representatives of the Sponsor (-Investigator), a competent authority (e.g. Swissmedic), or an ethics committee may require direct access to parts of the medical records relevant to the study, including participants' medical history.

Locations